Implantable monitor aims to keep shock survivors out of hospital

NCT ID NCT04419480

Recruiting now Disease control Sponsor: Inova Health Care Services Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether an implanted heart pressure monitor (CardioMEMS) can help prevent complications in 40 patients who survived cardiogenic shock. Participants will have the device implanted and receive regular pressure checks and medication adjustments. The goal is to see if this approach reduces deaths, hospital stays, and improves quality of life over 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CardioMEMS device (implanted heart pressure monitor)
What this could lead to: If successful, this could show that regular pressure monitoring helps prevent hospital readmissions and improves quality of life after cardiogenic shock.
What could go wrong: This is a small pilot study with only 40 participants, so results may not apply broadly. The device requires implantation, which carries procedural risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMBULATORY HEMODYNAMIC MONITORING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiogenic shock heart failure Shock, Cardiogenic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AMBULATORY HEMODYNAMIC MONITORING CARDIOGENIC SHOCK HEART FAILURE

Contacts and locations

Locations

Inova Fairfax Medical Campus
RECRUITING

Falls Church, Virginia, 22042, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.